• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

McCarter & English Logo

  • People
  • Services
  • Insights
  • Our Firm
    • Leadership Team
    • Social Justice
    • Diversity, Equity & Inclusion
    • Pro Bono
    • Client Service Values
    • Alumni
  • Join Us
    • Lawyers
    • Summer Associates
    • Patent Professionals
    • Professional Staff
    • Job Openings
  • Locations
    • Boston
    • Philadelphia
    • East Brunswick
    • Indianapolis
    • Stamford
    • Hartford
    • Trenton
    • Miami
    • Washington, DC
    • New York
    • Wilmington
    • Newark
  • Share

Share

Browse Alphabetically:

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
Bankruptcy, Restructuring & Litigation
Blockchain, Smart Contracts & Digital Currencies
Business Litigation
Cannabis
Coronavirus Resource Center
Corporate
Crisis Management
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Energy & Utilities
Environment & Energy
Financial Institutions
Food & Beverage
Government Affairs
Government Contracts & Global Trade
Government Investigations & White Collar Defense
Healthcare
Hospitality
Immigration
Impact Investing
Insurance Recovery, Litigation & Counseling
Intellectual Property
Labor & Employment
Life Sciences
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Public Finance
Real Estate
Renewable Energy
Sports & Entertainment
Tax & Employee Benefits
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients
Venture Capital & Emerging Growth Companies
  • Broadcasts
  • Events
  • News
  • Publications
  • View All Insights
Search By:
venture capital
Main image for Venture Capital & Emerging Growth Companies March 2020 Highlights
Publications|Alert

Venture Capital & Emerging Growth Companies March 2020 Highlights

Venture Capital & Emerging Growth Companies March Highlights

3.19.2020

We hope that you are all well, taking reasonable precautions, and that your health and businesses remain strong. Your McCarter team is working as usual (albeit remotely) and remains steadfast in our commitment to helping our clients achieve their goals and meet today’s unique challenges. We are working collaboratively across our practices to provide you with the most timely information concerning the Coronavirus pandemic on our Coronavirus Task Force Resource Center. We also will reach out to our contacts proactively as information important to their business operations becomes available.

You may be interested in New York City’s newly adopted employee retention grant program available to New York City-based small businesses with no more than four employees suffering a 25% or more decrease in revenue as a result of COVID-19. If you are a startup/emerging growth company or a venture capital firm with portfolio companies that might qualify for this program, please reach out to us with any questions.

Many of our publicly held clients are in the midst of proxy and annual meeting season. In light of the COVID-19 problems, as well as state and local mandates prohibiting large group meetings, the staff of the Division of Corporate Financing and the Division of Investment Management of the U.S. Securities and Exchange Commission published guidance on March 13, 2020, that relates to public companies conducting their annual meetings virtually instead of in-person. Please click here for more information.

For New Jersey businesses that are being financially and/or operationally impacted by the coronavirus outbreak, the New Jersey Economic Development Authority (NJEDA) has set up an information page to address concerns. In addition to a portfolio of loan, financing, and technical assistance programs available to support the small and medium-sized businesses affected, the NJEDA has programs, initiatives, and incentives for all technology and life sciences enterprises, entrepreneurs, and investors. The materials are provided for your reference on this page.

McCarter has a thriving life sciences practice that brings substantial experience in the pharmaceutical, medical device, biotechnology, and healthcare fields to established organizations and startup life sciences ventures. We are proud to collaborate with Mount Sinai Innovation Partners on its pitch challenge programming, where our attorneys will act as mentors and hear teams present their technology-based ideas and innovative products. 

Lawyers in McCarter’s Venture Capital & Emerging Growth Companies Practice group empower clients throughout the development cycle—from ideation to creation, capitalization, implementation, commercialization and monetization.

Media Mentions

2.3.2020 Amy Haberman authored “New Form I-9 Required as of January 31, 2020”—Immigration Alert

2.11.2020 Zack Hadzismajlovic and Ronald M. Leibman discussed “CFIUS: Final Regulations Governing Review of Foreign Investment in US Businesses and Real Estate”—McCarter On Demand Podcast

Additional Resources

sidebar

pdfemail

Related Services

Venture Capital & Emerging Growth Companies
Corporate
Subscribe to our Insights
McCarter & English, LLP
Copyright © 2023 McCarter & English, LLP. All Rights Reserved.
  • Login
  • Attorney Advertising
  • Privacy
  • Awards Methodology
  • Contact
  • Subscribe
  • Sitemap

The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.

Accept Cancel